ITIH4 and infection: Similarly, passive administration of the CD4bs-specific mAb b12 to newborn macaques prior to virus challenge augmented de novo Ab response to challenge SHIV virus in terms of gp120-binding and virus-neutralizing titers (59), corroborating the idea that preexisting or exogenously administered Abs influence the quality of immune responses to subsequent antigen exposure from infection or vaccination.